Your browser is no longer supported. Please, upgrade your browser.
Settings
CORT Corcept Therapeutics Incorporated daily Stock Chart
CORT [NASD]
Corcept Therapeutics Incorporated
Index- P/E7.87 EPS (ttm)1.45 Insider Own2.70% Shs Outstand111.36M Perf Week0.18%
Market Cap1.27B Forward P/E14.62 EPS next Y0.78 Insider Trans-0.86% Shs Float104.38M Perf Month-23.85%
Income185.00M PEG- EPS next Q0.15 Inst Own78.40% Short Float24.26% Perf Quarter-5.71%
Sales237.70M P/S5.34 EPS this Y35.70% Inst Trans-1.33% Short Ratio13.06 Perf Half Y-16.48%
Book/sh2.24 P/B5.09 EPS next Y36.84% ROA58.50% Target Price13.80 Perf Year-27.71%
Cash/sh1.75 P/C6.50 EPS next 5Y-11.90% ROE66.80% 52W Range9.14 - 20.00 Perf YTD-14.67%
Dividend- P/FCF10.69 EPS past 5Y39.00% ROI85.00% 52W High-43.00% Beta1.25
Dividend %- Quick Ratio5.40 Sales past 5Y117.00% Gross Margin98.00% 52W Low24.73% ATR0.77
Employees136 Current Ratio5.60 Sales Q/Q50.50% Oper. Margin36.30% RSI (14)45.77 Volatility5.40% 7.70%
OptionableYes Debt/Eq0.00 EPS Q/Q28.50% Profit Margin63.80% Rel Volume0.58 Prev Close11.09
ShortableYes LT Debt/Eq0.00 EarningsFeb 28 AMC Payout0.00% Avg Volume1.94M Price11.40
Recom2.80 SMA20-0.66% SMA50-13.53% SMA200-19.95% Volume1,124,611 Change2.80%
Feb-04-19Downgrade B. Riley FBR Buy → Neutral $22 → $12
Aug-10-18Reiterated Stifel Hold $20 → $11
May-31-18Downgrade Stifel Buy → Hold $20
Mar-09-18Initiated B. Riley FBR, Inc. Buy $30
Aug-31-17Initiated Stifel Buy $20
Feb-02-17Initiated Ladenburg Thalmann Buy $14
Apr-21-15Initiated FBR Capital Outperform $12
Jan-13-14Downgrade Stifel Buy → Hold
Aug-09-13Downgrade Ladenburg Thalmann Buy → Neutral $3.30
Aug-09-13Downgrade Janney Buy → Neutral
Feb-21-12Reiterated JMP Securities Mkt Outperform $9 → $11
Jan-06-10Upgrade Ladenburg Thalmann Neutral → Buy $4
Jul-17-08Initiated Rodman & Renshaw Mkt Outperform $8
Jun-21-07Upgrade Punk, Ziegel & Co Mkt Perform → Accumulate
Feb-19-19 04:05PM  Corcept Therapeutics To Announce Audited Financial Results, Provide Corporate Update And Host Conference Call GlobeNewswire
Feb-11-19 08:31PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Corcept Therapeutics Incorporated Investors Business Wire
07:20AM  Recent Analysis Shows Corcept Therapeutics, CDK Global, Dynavax Technologies, ICU Medical, American Vanguard, and Cabot Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Feb-08-19 08:50AM  Options Traders Expect Huge Moves in Corcept (CORT) Stock Zacks
Feb-07-19 04:13PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Corcept Therapeutics Incorporated Investors Business Wire
Feb-06-19 08:29AM  Investors Are Undervaluing Corcept Therapeutics Incorporated (NASDAQ:CORT) By 49.63% Simply Wall St. +5.27%
Feb-05-19 04:34PM  Investor Alert: Kaplan Fox Investigates Corcept Therapeutics Incorporated PR Newswire +7.94%
02:58PM  Puts Pop Amid Drug Stock's Roller-Coaster Session Schaeffer's Investment Research
Feb-01-19 12:17PM  Here's Why Corcept Therapeutics Fell as Much as 13.7% Today Motley Fool -10.29%
Jan-31-19 04:05PM  Corcept Therapeutics Announces Fourth Quarter and Full-Year 2018 Preliminary Selected Financial Results; Provides 2019 Revenue Guidance GlobeNewswire
Jan-25-19 05:00PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Corcept Therapeutics Incorporated GlobeNewswire -11.01%
03:55PM  Here's Why Corcept Therapeutics Stock Fell as Much as 18.5% Today Motley Fool
02:17PM  Corcept Puts Active After Negative Report Schaeffer's Investment Research
Jan-11-19 01:15PM  Can Corcept Therapeutics Incorporated (NASDAQ:CORT) Maintain Its Strong Returns? Simply Wall St.
Dec-30-18 03:27PM  The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials Benzinga
Dec-19-18 11:39PM  Is Corcept Therapeutics Incorporated (CORT) A Good Stock To Buy? Insider Monkey -8.78%
Dec-13-18 09:30AM  Biotech Companies in the News ACCESSWIRE
08:35AM  Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushings Syndrome GlobeNewswire
Dec-12-18 04:43PM  IBD 50 Stocks To Watch: Corcept Expected To Pick Up Growth In 2019 Investor's Business Daily
06:50AM  Today's Research Reports on Trending Tickers: MYOS RENS Technology and Corcept Therapeutics ACCESSWIRE
Dec-11-18 04:58PM  Here's Why Corcept Therapeutics Surged Today Motley Fool +32.28%
04:26PM  Here's Why Corcept Therapeutics Rose 18.6% in November Motley Fool
Nov-30-18 08:15AM  Report: Exploring Fundamental Drivers Behind Tesla, Nordson, Paycom Software, PDL BioPharma, Corcept Therapeutics, and Willis Towers Watson Public New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-26-18 08:35AM  What You Must Know About Corcept Therapeutics Incorporateds (NASDAQ:CORT) Financial Strength Simply Wall St. +5.11%
Nov-20-18 04:24PM  Corcept Initiates Phase III Study for Cushing's Syndrome Zacks
Nov-19-18 09:05AM  Corcept Therapeutics Announces First Patient Dosed in Phase 3 Trial of Relacorilant to Treat Patients with Cushings Syndrome GlobeNewswire -7.14%
Nov-14-18 09:46PM  Edited Transcript of CORT earnings conference call or presentation 1-Nov-18 9:00pm GMT Thomson Reuters StreetEvents
Nov-05-18 02:25PM  Corcept (CORT) Q3 Earnings In Line, Revenues Miss Estimates Zacks
Nov-01-18 08:15PM  Corcept Therapeutics (CORT) Meets Q3 Earnings Estimates Zacks
07:09PM  Corcept: 3Q Earnings Snapshot Associated Press
04:05PM  Corcept Therapeutics Announces Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Oct-31-18 02:52PM  Is Corcept Therapeutics Incorporateds (NASDAQ:CORT) CEO Incentives Align With Yours? Simply Wall St.
Oct-25-18 04:05PM  Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call GlobeNewswire
Oct-24-18 08:05AM  Judge Denies Teva Pharmaceuticals Motion to Dismiss Corcept Therapeutics Allegations of Patent Infringement GlobeNewswire -7.99%
Oct-23-18 09:00AM  Report: Exploring Fundamental Drivers Behind Corcept Therapeutics, News Corporation, Nightstar Therapeutics PLC Sponsored ADR, Rudolph Technologies, Applied Optoelectronics, and United Rentals New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-04-18 10:08AM  Should You Be Holding Corcept Therapeutics Incorporated (NASDAQ:CORT) Right Now? Simply Wall St. -5.93%
Oct-01-18 07:15AM  Corcept Therapeutics Receives Orphan Designation for Relacorilant as Treatment for Pancreatic Cancer GlobeNewswire
Sep-12-18 08:52AM  Do Options Traders Know Something About Corcept (CORT) Stock We Don't? Zacks
Sep-04-18 08:03AM  Why These Fundamentals Make Corcept Therapeutics Incorporated (NASDAQ:CORT) Truly A Standout Investment Simply Wall St.
Aug-30-18 06:04PM  8 Stocks Joel Greenblatt Continues to Buy GuruFocus.com
Aug-29-18 07:35AM  Analysis: Positioning to Benefit within ShotSpotter, Frank's International N.V., Taseko Mines, Office Depot, Rudolph Technologies, and Corcept Therapeutics Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire +7.40%
Aug-26-18 11:55PM  Edited Transcript of CORT earnings conference call or presentation 9-Aug-18 9:00pm GMT Thomson Reuters StreetEvents
Aug-25-18 06:01PM  Insider Buys Of The Week: Andeavor, Corcept, Portola Benzinga
Aug-24-18 07:30AM  [$$] Corcept Director Abruptly Switches to Buying Stock From Selling Barrons.com
Aug-20-18 04:57PM  3 High-Growth Stocks That Could Soar Motley Fool
Aug-10-18 12:38PM  Here's Why Corcept Therapeutics Inc. Fell as Much as 17.4% Today Motley Fool -5.15%
10:59AM  Corcept (CORT) Earnings and Revenues Miss Estimates in Q2 Zacks
08:00AM  Today's Research Reports on Trending Tickers: Puma Biotechnology and Corcept Therapeutics ACCESSWIRE
07:38AM  The Daily Biotech Pulse: Puma, CareDx Soar On Earnings, Corcept Plunges On Bottom-Line Miss Benzinga
Aug-09-18 06:30PM  Corcept Therapeutics (CORT) Misses Q2 Earnings and Revenue Estimates Zacks
05:26PM  Corcept: 2Q Earnings Snapshot Associated Press
04:05PM  Corcept Therapeutics Announces Second Quarter 2018 Financial Results and Stock Repurchase Program; Provides Clinical Update GlobeNewswire
03:00PM  Corcept Therapeutics Incorporated. to Host Earnings Call ACCESSWIRE
Aug-02-18 04:05PM  Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call GlobeNewswire
Jul-27-18 07:35AM  Initiating Free Research Reports on Celgene and Three Other Biotech Equities ACCESSWIRE
Jun-29-18 09:23AM  Options Traders Expect Huge Moves in Corcept Therapeutics (CORT) Stock Zacks
08:15AM  Analysis: Positioning to Benefit within QEP Resources, Corcept Therapeutics, Buckle, Noble Energy, Windstream, and Camden Property Trust Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jun-27-18 10:04AM  How Corcept Therapeutics Incorporated (NASDAQ:CORT) Delivered A Better ROE Than Its Industry Simply Wall St.
Jun-25-18 07:05AM  Today's Free Research Reports Coverage on CorMedix and Three More Biotech Stocks ACCESSWIRE
Jun-19-18 02:05PM  Corcept Therapeutics Incorporated (NASDAQ:CORT) Has Attractive Fundamentals, Heres Why Simply Wall St.
08:20AM  Today's Research Reports on Trending Tickers: Corcept Therapeutics and CRISPR Therapeutics ACCESSWIRE
Jun-07-18 09:42AM  Corcept Therapeutics (CORT) Up 6.6% Since Earnings Report: Can It Continue? Zacks
Jun-04-18 05:30AM  Corcept Therapeutics Announces Positive Relacorilant Data at the 2018 American Society of Clinical Oncology Meeting GlobeNewswire
May-31-18 12:52PM  Corcept Therapeutics Is 'Fairly Valued,' Stifel Says In Downgrade Benzinga -6.04%
May-25-18 08:30AM  Today's Research Reports on Trending Tickers: Corcept Therapeutics and Verastem ACCESSWIRE
May-21-18 08:00AM  Today's Research Reports on Trending Tickers: Nektar Therapeutics and Corcept Therapeutics ACCESSWIRE
May-17-18 04:13PM  Gilead, BioMarin among Bay Area drug makers shamed by FDA in generics 'gaming' list American City Business Journals
07:50AM  Market Trends Toward New Normal in Agios Pharmaceuticals, Corcept Therapeutics, Prestige Brand, Virtu Financial, Eagle Pharmaceuticals, and Century Aluminum Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
May-16-18 08:30AM  Corcept Therapeutics Announces Presentations at the American Association of Clinical Endocrinologists 27th Annual Congress GlobeNewswire
May-14-18 08:40AM  Is the Options Market Predicting a Spike in Corcept Therapeutics (CORT) Stock? Zacks +5.93%
May-12-18 10:02AM  May Undervalued Stock Opportunities Simply Wall St.
May-11-18 07:46PM  Edited Transcript of CORT earnings conference call or presentation 8-May-18 9:00pm GMT Thomson Reuters StreetEvents
May-08-18 06:55PM  Corcept: 1Q Earnings Snapshot Associated Press
04:05PM  Corcept Therapeutics Announces First Quarter 2018 Financial results and Provides Corporate Update GlobeNewswire
May-01-18 04:05PM  Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call GlobeNewswire
Apr-30-18 10:42AM  Corcept Therapeutics Incorporated (NASDAQ:CORT): Is It A Good Long Term Opportunity? Simply Wall St.
Apr-17-18 07:09PM  Should You Be Tempted To Buy Corcept Therapeutics Incorporated (NASDAQ:CORT) At Its Current PE Ratio? Simply Wall St.
Apr-06-18 02:23PM  10 Healthcare Stocks to Stave Off the Market Flu InvestorPlace
Mar-26-18 04:36AM  Why Is Corcept Therapeutics (CORT) Up 5.3% Since Its Last Earnings Report? Zacks
Mar-23-18 01:20PM  Edited Transcript of CORT earnings conference call or presentation 22-Feb-18 10:00pm GMT Thomson Reuters StreetEvents
Mar-15-18 05:00PM  Corcept Therapeutics Files Lawsuit Against Teva Pharmaceuticals for Infringement of Korlym Patents GlobeNewswire
Mar-12-18 12:45PM  Why Corcept Therapeutics Incorporated Lost 34% in February Motley Fool +5.20%
Mar-09-18 06:18PM  How Did Corcept Therapeutics Incorporateds (NASDAQ:CORT) 67.61% ROE Fare Against The Industry? Simply Wall St.
Mar-08-18 07:24PM  Corcept Plans Korlym Label Expansion, Pipeline in Progress Zacks
Mar-02-18 07:40AM  Wired News Sangamo Gets CTA from UK Agency for Evaluating SB-FIX for Treatment of Hemophilia B ACCESSWIRE
07:35AM  New Research: Key Drivers of Growth for Corcept Therapeutics, HubSpot, Tableau Software, Balchem, Steelcase, and Chimerix Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Feb-23-18 08:55AM  Corcept's (CORT) Earnings and Sales Meet Estimates in Q4 Zacks
Feb-22-18 06:31PM  Corcept misses 4Q profit forecasts Associated Press
04:05PM  Corcept Therapeutics Announces 2017 Financial Results and Positive Interim Results of Relacorilant Phase 2 Trial GlobeNewswire
01:00PM  Corcept Therapeutics Incorporated. to Host Earnings Call ACCESSWIRE
Feb-15-18 04:05PM  Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2017 Financial Results, Provide Corporate Update, Host Conference Call GlobeNewswire
Feb-13-18 05:12PM  Why Corcept Therapeutics Stock Gained 27.4% in January Motley Fool
Feb-07-18 07:16PM  Cramer's lightning round: Buy Target on its revamped stra... CNBC Videos
06:48PM  Cramer's lightning round: Buy Target on its revamped strategy CNBC
Feb-05-18 04:30PM  These Biotech Stocks Each Dived More Than 20% Is The Sell-Off Overdone? Investor's Business Daily -26.43%
03:40PM  Why Corcept Therapeutics Incorporated Stock Is Getting Clobbered Today Motley Fool
08:49AM  Corcept's stock tumbles after Teva submits NDA for generic Korlym MarketWatch
Feb-01-18 04:02PM  Biotech Roundup: Who's Popping On Drug, Merger, Earnings News? Investor's Business Daily +5.54%
08:30AM  Corcept Therapeutics Announces Fourth Quarter and Full-Year 2017 Preliminary Selected Financial Results; Provides 2018 Revenue Guidance GlobeNewswire
Jan-31-18 08:20AM  Todays Research Reports on Trending Tickers: Bellicum Pharmaceuticals and Corcept Therapeutics ACCESSWIRE
Corcept Therapeutics Incorporated, a pharmaceutical company, discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery, as well as develops CLIA-validated assay to measure FKBP5 gene expression. It is developing relacorilant that is in a Phase II trial to treat patients with Cushing's syndrome; abraxane in combination with relacorilant, which is in Phase I/II open label trial to treat solid tumors; and selective cortisol modulator CORT125281 combined with Xtandi that is in open label Phase I/II trial to treat patients with metastatic castration-resistant prostate cancer. The company is also developing CORT118335 selective cortisol modulator, which is in Phase I/II open label trial for the treatment of antipsychotic-induced weight gain and non-alcoholic steatotic hepatitis. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Maduck SeanSee RemarksDec 13Option Exercise2.2410,00022,40030,024Dec 14 08:12 PM
Maduck SeanSee RemarksDec 12Option Exercise2.7860,000166,80680,024Dec 14 08:12 PM
BELANOFF JOSEPH KChief Executive OfficerDec 12Option Exercise1.19217,115258,3672,381,310Dec 14 07:50 PM
Robb Gary CharlesChief Financial OfficerDec 12Option Exercise1.9225,00048,00021,858Dec 14 07:51 PM
Robb Gary CharlesChief Financial OfficerDec 12Sale19.0125,000475,1536,858Dec 14 07:51 PM
BELANOFF JOSEPH KChief Executive OfficerDec 12Sale19.01217,1154,126,5092,164,195Dec 14 07:50 PM
Maduck SeanSee RemarksDec 12Sale19.0160,0001,140,36620,024Dec 14 08:12 PM
BAKER G LEONARD JRDirectorNov 21Buy12.7370,000890,7853,044,793Nov 26 05:13 PM
BAKER G LEONARD JRDirectorNov 21Buy12.7330,000381,765966,838Nov 26 05:13 PM
BAKER G LEONARD JRDirectorNov 13Buy12.8725,420327,1052,974,793Nov 14 05:26 PM
BAKER G LEONARD JRDirectorNov 13Buy12.8710,895140,197936,838Nov 14 05:26 PM
BAKER G LEONARD JRDirectorNov 12Buy12.9473,914956,6982,949,373Nov 14 05:26 PM
BAKER G LEONARD JRDirectorNov 12Buy12.9431,677410,008925,943Nov 14 05:26 PM
BAKER G LEONARD JRDirectorNov 09Buy13.0040,666528,6582,875,459Nov 14 05:26 PM
BAKER G LEONARD JRDirectorNov 09Buy13.0017,428226,564894,266Nov 14 05:26 PM
FISHMAN ROBERT SChief Medical OfficerNov 07Option Exercise3.518,00028,0808,000Nov 09 05:06 PM
FISHMAN ROBERT SChief Medical OfficerNov 07Sale13.748,000109,8870Nov 09 05:06 PM
FISHMAN ROBERT SChief Medical OfficerOct 08Option Exercise3.518,00028,0808,000Oct 09 05:11 PM
FISHMAN ROBERT SChief Medical OfficerOct 08Sale13.198,000105,5380Oct 09 05:11 PM
FISHMAN ROBERT SChief Medical OfficerSep 07Option Exercise3.518,00028,0808,000Sep 11 04:36 PM
FISHMAN ROBERT SChief Medical OfficerSep 07Sale14.578,000116,5330Sep 11 04:36 PM
BAKER G LEONARD JRDirectorAug 20Buy12.9235,681461,0952,834,793Aug 22 05:54 PM
BAKER G LEONARD JRDirectorAug 17Buy12.805,79274,1172,799,112Aug 20 06:19 PM
BAKER G LEONARD JRDirectorAug 16Buy12.49100,0001,248,7602,793,320Aug 20 06:19 PM
BAKER G LEONARD JRDirectorAug 15Buy12.4979,686994,9672,693,320Aug 16 05:51 PM
BAKER G LEONARD JRDirectorAug 14Buy12.47100,0001,247,000876,838Aug 16 05:51 PM
FISHMAN ROBERT SChief Medical OfficerAug 07Option Exercise3.518,00028,0808,000Aug 08 05:20 PM
FISHMAN ROBERT SChief Medical OfficerAug 07Sale14.158,000113,1850Aug 08 05:20 PM
FISHMAN ROBERT SChief Medical OfficerJul 06Option Exercise3.518,00028,0808,000Jul 09 07:50 PM
FISHMAN ROBERT SChief Medical OfficerJul 06Sale15.098,000120,6860Jul 09 07:50 PM
WILSON JAMES NDirectorJun 29Option Exercise2.3010,00023,00010,000Jul 02 06:44 PM
FISHMAN ROBERT SChief Medical OfficerJun 07Option Exercise3.518,00028,0808,000Jun 11 05:07 PM
FISHMAN ROBERT SChief Medical OfficerJun 07Sale18.238,000145,8260Jun 11 05:07 PM
Maduck SeanSee RemarksMay 15Option Exercise2.2410,00022,40020,024May 17 05:27 PM
BAKER G LEONARD JRDirectorMay 11Option Exercise2.2330,00066,900806,838May 15 05:30 PM
BAKER G LEONARD JRDirectorMay 11Sale16.0130,000480,312776,838May 15 05:30 PM
FISHMAN ROBERT SChief Medical OfficerMay 07Option Exercise3.518,00028,0808,000May 08 06:54 PM
FISHMAN ROBERT SChief Medical OfficerMay 07Sale17.688,000141,4280May 08 06:54 PM
FISHMAN ROBERT SChief Medical OfficerApr 06Option Exercise3.518,00028,0808,000Apr 09 05:57 PM
FISHMAN ROBERT SChief Medical OfficerApr 06Sale16.228,000129,7840Apr 09 05:57 PM
FISHMAN ROBERT SChief Medical OfficerMar 07Option Exercise3.518,00028,0808,000Mar 08 07:11 PM
GALA RENEE DDirectorMar 07Buy15.539,000139,80210,000Mar 07 08:38 PM
FISHMAN ROBERT SChief Medical OfficerMar 07Sale15.678,000125,3230Mar 08 07:11 PM
GALA RENEE DDirectorMar 06Buy15.301,00015,3001,000Mar 07 08:38 PM